From Benign To Malignant: A Case Report of Male Breast Cancer Mimicking Gynecomastia

Authors

  • Made Adwitya Krisna Kinasih Rumah Sakit Kertha Usada
  • Ketut Suparna Rumah Sakit Umum Daerah Buleleng

DOI:

https://doi.org/10.55606/ijhs.v5i3.6207

Keywords:

Breast Cancer, Diagnosis Dini, Male Gynecomastia, Mature Male, Terapi Tamoxifen

Abstract

Introduction: Carcinoma of the male breast is a very uncommon malignancy and accounts for less than 1% of all cases of breast carcinoma. The nonspecific presentation, along with low clinical suspicion, usually results in diagnosis at a delayed stage and poorer outcomes. Gynecomastia is a benign proliferation of male breast tissue and is the most common differential diagnosis that can mask underlying malignancy. Objective: To present a rare case of male breast cancer initially misdiagnosed as gynecomastia, and to emphasize the importance of early recognition and accurate differentiation between benign and malignant male breast conditions. Case Report: A 40-year-old male patient presented with a progressively enlarging right breast mass, which was earlier diagnosed as gynecomastia. The mass had been present since childhood but showed notable growth over the past two years. Physical examination revealed a hard, immobile, tender mass, 7 × 10 cm in size, without nipple discharge or axillary lymphadenopathy. Histopathology confirmed mixed carcinoma: invasive carcinoma of no special type with invasive lobular carcinoma. No metastasis was seen on imaging studies. Immunohistochemistry showed ER(+), PR(+), HER2(-), and Ki-67 at 20%. The patient underwent modified radical mastectomy, chemotherapy, and tamoxifen therapy, with no recurrence observed at six-month follow-up. Discussion: This case represents the diagnostic dilemma in differentiating male breast cancer from gynecomastia, particularly in young males without any risk factors. The diagnosis is even difficult when it is an invasive lobular carcinoma or a mixed type. Imaging and biopsy remain important in the management. Conclusion: Clinicians should have a high index of suspicion for malignancy when dealing with male breast masses. A timely diagnosis ensures appropriate treatment and results in better patient outcomes.

Downloads

Download data is not yet available.

References

Aranda-Gutierrez, A., & Diaz-Perez, H. (2023). Histology, mammary glands. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK547732/

Christgen, M., Cserni, G., Floris, G., Marchio, C., Djerroudi, L., Kreipe, H., et al. (2021). Lobular breast cancer: Histomorphology and different concepts of a special spectrum of tumors. Cancers (Basel), 13(15), 3695. https://www.mdpi.com/2072-6694/13/15/3695

Devesa, S. S., Blot, W. J., Stone, B. J., Miller, B. A., Tarone, R. E., & Fraumeni, J. F. (1995). Recent cancer trends in the United States. JNCI: Journal of the National Cancer Institute, 87(3), 175–182. https://doi.org/10.1093/jnci/87.3.175

Fentiman, I. S. (2023). Risk factors for male breast cancer. American Journal of Translational Research, 15(12), 6918–6925. http://www.ncbi.nlm.nih.gov/pubmed/38186995

Floris, G., Djerroudi, L., Zels, G., De Schepper, M., Richard, F., Brahimaj, R., et al. (2025). Pitfalls in the histological diagnosis of morphologic variants of invasive lobular carcinoma of the breast. Modern Pathology, 38(9), 100837. https://linkinghub.elsevier.com/retrieve/pii/S0893395225001346

Hassett, M. J., Somerfield, M. R., Baker, E. R., Cardoso, F., Kansal, K. J., Kwait, D. C., et al. (2020). Management of male breast cancer: ASCO guideline. Journal of Clinical Oncology, 38(16), 1849–1863. https://doi.org/10.1200/JCO.19.03120

Hill, T. D., Khamis, H. J., Tyczynski, J. E., & Berkel, H. (J.) (2005). Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Annals of Epidemiology, 15(10), 773–780. https://linkinghub.elsevier.com/retrieve/pii/S1047279705000128

Mannix, J., Duke, H., Almajnooni, A., & Ongkeko, M. (2024). Imaging the male breast: Gynecomastia, male breast cancer, and beyond. RadioGraphics, 44(6). https://doi.org/10.1148/rg.230181

Mekheal, E., Kania, B. E., Kumari, P., Kumar, V., & Maroules, M. (2022). Gynecomastia and malignancy: A case of male invasive ductal breast carcinoma treated with neoadjuvant chemotherapy. American Journal of Case Reports, 23. https://www.amjcaserep.com/abstract/index/idArt/937370

Metzger-Filho, O., Ferreira, A. R., Jeselsohn, R., Barry, W. T., Dillon, D. A., Brock, J. E., et al. (2019). Mixed invasive ductal and lobular carcinoma of the breast: Prognosis and the importance of histologic grade. The Oncologist, 24(7), e441–e449. https://doi.org/10.1634/theoncologist.2018-0538

Spreafico, F. S., Cardoso-Filho, C., Cabello, C., Sarian, L. O., Zeferino, L. C., & Vale, D. B. (2020). Breast cancer in men: Clinical and pathological analysis of 817 cases. American Journal of Men’s Health, 14(4). https://doi.org/10.1177/1557988320908109

Swamy, N., Rohilla, M., Raichandani, S., & Bryant-Smith, G. (2021). Epidemiology of male breast diseases: A 10-year institutional review. Clinical Imaging, 72, 142–150. https://linkinghub.elsevier.com/retrieve/pii/S0899707120304551

Vadakekut, E., & Puckett, Y. (2025). New palpable breast mass. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK560757/

Zheng, G., & Leone, J. P. (2022). Male breast cancer: An updated review of epidemiology, clinicopathology, and treatment. In H. Han (Ed.), Journal of Oncology, 2022, 1–11. https://www.hindawi.com/journals/jo/2022/1734049/

Downloads

Published

2025-11-15

How to Cite

Made Adwitya Krisna Kinasih, & Ketut Suparna. (2025). From Benign To Malignant: A Case Report of Male Breast Cancer Mimicking Gynecomastia. International Journal Of Health Science, 5(3), 289–295. https://doi.org/10.55606/ijhs.v5i3.6207